Temps réel estimé
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
2,23 USD | +0,45% | -5,74% | -65,77% |
30/04 | Processa Pharmaceuticals, Inc. nomme Steven Cha au poste de Senior Vice President de la recherche clinique | CI |
26/04 | Principales baisses du prémarché | MT |
Métier
Nombre d'employés: 13
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Wendy Guy
FOU | Founder | 59 | 29/03/11 |
Sian Bigora
FOU | Founder | 63 | 29/03/11 |
David Young
FOU | Founder | 71 | 29/03/11 |
Patrick Lin
FOU | Founder | 58 | 29/03/11 |
George Ng
CEO | Chief Executive Officer | 49 | 08/08/23 |
Jim Stanker
DFI | Director of Finance/CFO | 67 | 05/09/18 |
Weifei Ye
CTO | Chief Tech/Sci/R&D Officer | - | - |
Kayla Parks
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | - | |
Mary Nyberg
PRN | Corporate Officer/Principal | - | - |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
George Ng
CEO | Chief Executive Officer | 49 | 08/08/23 |
James Neal
BRD | Director/Board Member | 68 | 16/07/22 |
Justin Yorke
CHM | Chairman | 58 | 02/10/17 |
Patrick Lin
FOU | Founder | 58 | 29/03/11 |
David Young
FOU | Founder | 71 | 29/03/11 |
Director/Board Member | 66 | 11/07/22 | |
Geraldine Pannu
BRD | Director/Board Member | 54 | 13/02/20 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 2 862 896 | 2 534 087 ( 88,51 %) | 5 000 ( 0,1746 %) | 88,51 % |
Coordonnées société
Processa Pharmaceuticals, Inc.
7380 Coca Cola Drive Suite 106
21076, Hanover
+
http://www.processapharma.comSecteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-65,77% | 6,34 M | |
+30,27% | 699 Md | |
+25,07% | 571 Md | |
-4,68% | 364 Md | |
+18,23% | 326 Md | |
+2,84% | 286 Md | |
+14,68% | 236 Md | |
+4,71% | 198 Md | |
-12,43% | 194 Md | |
-3,75% | 154 Md |
- Bourse
- Actions
- Action PCSA
- Société Processa Pharmaceuticals, Inc.